Loubani Mahmoud

GMC: 4469571

Hospital(s): Hull and East Yorkshire Hospitals NHS Trust

Special Interests: Adult Cardiac Surgery, Thoracic Surgery

I am a Consultant Cardiothoracic Surgeon since 2009 and have special interest in aortic surgery and minimally invasive thoracic surgery.

Training Attended
  • Graduate of the Royal College of Surgeons in Ireland Medical School 1992
  • Internship in James Conolly Memorial Hospital, Dublin, Ireland 1992-1993
  • Southwest of Ireland Basic Surgical Training Programme 1993-1996
  • Vascular and Thoracic Surgery Registrar, St Vincets Hospital, Dublin 1996-1998
  • Clinical Research Fellow, Glenfield Hospital, Leicester 1998-2001
  • West Midlands Cardiothoracic Surgical Training Programme 2001-2009
Qualifications & Accreditations
Qualifications
  • MB, BCh, LRCP & SI, BAO, (NUI) RCSI Medical School 5th June 1992
  • FRCSI, June 1996.
  • MD, University of Leicester, July 2005.
  • FRCS(CTh), October 2006.
  • Diploma in Health Services Management, Keele University, July 2007
  • FETCS, European Board of Thoracic and Cardiovascular Surgery, September 2010
  • FRCS, July 2011
  • Masters in Medical Education, University of Warwick, November 2012
Current Posts
  • Consultant Cardiothoracic Surgeon from 1st April 2009
  • Lead for Surgery NIHR Yorkshire and Humber CRN from October 2014
  • Honorary Professor of Cardiothoracic Surgery for Hull York Medical School from November 2015
  • Yorkshire & the Humber Cardiothoracic Surgery TPD from 1st August 2017
  • Director of Surgical Research and Innivation for Hull and East Yorkshire Hospitals Trust from 1st January 2018
 
Additional Information
  • Fellow of the Academy of Medical Educators
  • Fellow of the Faculty of Surgical Trainers of the Royal College of Surgeons of Edinburgh
  • Senior Fellow of the Higher Education Academy

Number of lung cancer operations performed in 2017:  64

Mahmoud Loubani works as part of a team of thoracic surgeons at Hull and East Yorkshire Hospitals NHS Trust
Click here to see data on how this team performed in 2017, including;

  • the number of operations to remove lung cancer performed by each surgeon in the team
  • the adjusted survival rates 30, 90 and 365 days after surgery to remove lung cancer
  • the length of time (defined as median days) patients having cancer surgery at this Trust spend in hospital.
  • the percentage of patients readmitted to hospital within 90 days of surgery
  • the pooled resection rate of Trusts served by this surgical unit

This data comes from the Lung Cancer Clinical Outcomes Publication.  This project makes the results achieved by surgical teams treating lung cancer within NHS England available to the public.

The latest report covers operations performed in 2017.  More information about this project is available here.

Risk-adjusted in-hospital survival rate

This graph shows the “in hospital” survival rate of patients who are operated on by the individual surgeon/unit you have selected. “In hospital” means time the patient is in the hospital where they have had their operation. It does not include any time that patients may have spent in other hospitals, either before or after their heart operation.

The data has been through a complex methodology, including the variations in patient risk factors in order to give you a comparative base from which to work from. This means that the survival rates take into account the type and risk of patients being operated on for each surgeon/unit. This is known as risk adjusted survival.

The vertical axis shows the GMC number of the surgeon or the Hospital identifier. In brackets is the total number of patients operated on by the surgeon/unit and the percentage of patients for whom the survival is known. The horizontal axis is the percentage survival. The dashed vertical line shows the risk adjusted survival rate for the UK as a whole. The solid black horizontal line represents the surgeon/unit. What is important here is that the horizontal line crosses the vertical dashed line. If this occurs, it means that the surgeon/unit are within the expected outcomes given the case-mix and risk factors of the patients they operate on.

The icons that sit on the horizontal line should give you more information about your surgeon/team.

For example

The open square is the survival rate with no risk adjustments:
The X is the predicted survival with adjustments
The solid dot is the survival probability after the methodology has been applied.

  • If the solid dot is red it means survival is worse than expected
  • If the solid dot is black it means that it is within limits
  • If the solid dot is green it means that there is significantly higher survival than expected

There is a lot of information on these plots, but the takeaway message is that if the solid black line crosses the dashed vertical line then the survival rate for the surgeon/unit is within expectations and that there is no reason for any concern.

A more detailed explanation about these graphs and methodology can be found here: Graph Explanations